BB Good human data, but mixed outcomes or surrogate markers. How we grade →Clinical practice guideline (GRADE) · 14 questions, systematic reviews of placebo-controlled trials
Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
MB Demay, AG Pittas, DD Bikle, DL Diab, ME Kiely, M Lazaretti-Castro et al. The Journal of Clinical Endocrinology & Metabolism. 2024.
- In plain language
- Suggests against routine 25(OH)D testing and against intakes above the DRI for healthy adults under 75; prefers daily over intermittent high doses after 50.
- Limits
- Found no clear target level; optimal doses remain unclear. Funded by the Endocrine Society.
- Which of our grades it feeds
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Science summary: Vitamin D testing and dose: what your 25(OH)D number means, how much D3 moves it, and why more is not better
- DD Mostly mechanistic or early data. Shown openly. How we grade →Ratings card: Vitamin D3 (in the multivitamin): Bone health and normal immune function when your level is low (two claim rows, both D)
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Ratings card: Vitamin D3 2,000 IU (status): Maintaining vitamin D status (blood 25(OH)D) in adults with low sun exposure or low intake
- Source
- doi.org/10.1210/clinem/dgae290 · PubMed 38828931
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.